Clinical Trial Update: Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating inhaled doxorubicin for advanced solid tumors affecting the lungs has completed, including patients with lung cancer and mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Malignant Mesothelioma

Drugs mentioned

• Doxorubicin (inhaled) (doxorubicin)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Lung Cancer, Malignant Mesothelioma | Phase 1 | Status: COMPLETED